𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis

✍ Scribed by A.P. Wiita; N. Roubinian; Y. Khan; P.V. Chin-Hong; J.P. Singer; J.A. Golden; S. Miller

Book ID
115100322
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
347 KB
Volume
14
Category
Article
ISSN
1398-2273

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Question of using valganciclovir for cyt
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post–liver transplant recipients
✍ Ashok Jain; Ravi Mohanka; Mark Orloff; Peter Abt; Charlotte Ryan; Adel Bozorgzad πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 46 KB

We read the article by Park et al. with great interest. 1 The authors retrospectively studied the efficacy of low-dose oral valganciclovir (n Ο­ 49) compared with the standard dose of ganciclovir (n Ο­ 60) for the prevention of cytomegalovirus (CMV) disease in adult liver transplant recipients. The au